Beta Bionics, Inc.
BBNX· Nasdaq
Filed May 6, 2025 · 10-Q · 36 days after period end · 0000950170-25-064504
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Revenue | $17.64M | $12.93M |
| Net Income | -$28.66M | -$12.45M |
| EPS Diluted | -$0.93 | -$2.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Beta Bionics, Inc. · CIK 1674632 · Engraved from SEC EDGAR
ended Mar 31, 2025 · filed May 6, 2025 · 36 d after period end